Researchers from Clínic-IDIBAPS develop a cell immunotherapy to fight severe fungal infections
A team from Clínic-IDIBAPS has designed a new cellular immunotherapy strategy to enhance the immune system’s response against invasive fungal infec...
A team from Clínic-IDIBAPS has designed a new cellular immunotherapy strategy to enhance the immune system’s response against invasive fungal infec...
La Marató de 3Cat Foundation has selected eight projects led or participated in by research teams from Clínic, IDIBAPS, and ISGlobal to receive fun...
An international team headed by the IDIBAPS Bipolar and Depressive Disorders research group shows that skin temperature measured with a smartwatch...
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
IDIBAPS launched the first call of DYNAMIS (Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions). This IDIBAPS sche...
An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify which...
Two studies led by the IDIBAPS Liver Vascular Biology group, located at Esther Koplowitz Centre, headed by Jordi Gracia-Sancho, reveal the key role...
A team from Hospital Clínic-IDIBAPS has identified changes in brain connectivity in women who have recently experienced sexual assault and develope...
A team from the Clínic-IDIBAPS has led a study of the international consortium of neuroimage ENIGMA that has allowed us a better understanding of w...
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and cont...